The most effective natural Psoriasis treatment
Click on a box to see what we consider
the most effective natural Psoriasis treatment for you

WOMEN 39
AND UNDER		 MEN 39
AND UNDER		 WOMEN 40
AND UP		 MEN 40
AND UP		 CHILDREN
click here...click here...click here...click here...click here...

What is psoriasis?

Psoriasis is a chronic inflammatory skin condition. Skin cells divide six times faster than usual and build up on the skin's surface causing red, flaky patches called scales. The cause of the disease is unknown but immune dysfunction and chronic inflammation play a decisive role. In two to three percent of the population, psoriasis commonly begins between the ages of 30 and 40 and occurs equally in women and men.

Certain pharmaceutical drugs can provoke the disease. Psoriatic arthritis is a symptom of the chronic inflammation having worsened. Conventional treatment only treats the symptoms and does not offer a cure. As it involves chronic inflammation, the below-mentioned natural anti-inflammatory and immune system-normalizing nutritional supplements are often effective.

Which natural ingredients can have an effect on psoriasis?

Vitamin D, chondroitin, fish oils (EPA/DHA), folic acid and grape seed extract.

What effects do these ingredients have?

  • Reduce skin changes in psoriasis.
  • Reduce itchiness.
  • Reduce joint pain.
  • Reduce edema.

For the reader with a deeper interest:

How do these ingredients work?

  • Treat and prevent vitamin and mineral deficiencies.
  • Inhibit the production of the tumor necrosis factor (TNF)-alpha.
  • Inhibit the production of interleukin (IL)-1beta.
  • Inhibit lipoxygenase synthesis.
  • Inhibit cyclooxygenase-2 (COX-2) synthesis.
  • Inhibit the breakdown of collagenase phospholipases.
  • Inhibit the synthesis of eukotriene B4 and prostaglandin E2.

The information above is based on more than 8,400 articles published in scientific journals and which are available at MEDLINE, the world’s largest medical database. Below you will find a few of them listed:

References

  1. Altmeyer PJ, Matthes U, Pawlak F, et al. Antipsoriatic effect of fumaric acid derivatives. J Am Acad Dermatol 1994;30:977–81.
  2. Ameen M, Russell-Jones R. Fumaric acid esters: an alternative systemic treatment for psoriasis. Clin Experiment Dermatol 1999;24:361–4.
  3. Anon: Fish oil for the heart. Med Lett Drug Ther 1987; 29:7-10.
  4. Anti M, Marra G, Armelao F et al: Modulating effect of omega-3 fatty acids on the proliferative pattern of human colorectal mucosa. In: Hone et al: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury. Plenum Press, New York, NY; 1997.
  5. Ashley JM, Lowe NJ, Borok ME, Alfin-Slater RB. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. J Am Acad Dermatol 1988;19:76–82.
  6. Aslan A & Triadafilopoulus G: Fish oil fatty acid supplementation in active ulcerative colitis: A double-blind, placebo-controlled crossover study. Am J Gastroenterol 1992; 87:432-437.
  7. Bagchi D, Garg A, Krohn FL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of viamins C and E, and a grape seed proanthocyanidin extract in vitro. Research Communications in Molecular Pathology and Pharmacology. 1997;95(2),179-87.
  8. Baird MD & Hough JL: More on fish oils. N Engl J Med 1987; 316:626.
  9. Bazex A, Gaillet L, Bazex J. Gluten-free diet and psoriasis. Ann Dermatol Syphiligr 1976;103:648–50 [in French].
  10. Bittiner SB, Cartwright I, Tucker WFG, et al. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988;1:378-380
  11. Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988;i:378–80.
  12. Bonaa KH, Bjerve KS & Nordoy A: Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arteriosclerosis Thrombosis 1992; 12:675-681.
  13. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Warwick, Queensland, Australia: Phytotherapy Press, 1996, 103–7.
  14. Buckley MS, Goff AD & Knapp W: Fish oil interaction with warfarin. Ann Pharmacother 2004; 38:50-53.
  15. Carper, Jean (1993) Food: Your Miracle Medicine. HarperCollins. pages 445-446
  16. Conclusion: Dietary supplementation with fish oils for 4 months produced no improvements in psoriasis patients.
  17. Conclusion: EPA proved beneficial when 9 psoriasis patients were treated with 3.6 g EPA for up to a year.
  18. Dewsbury CE, Graham P, Darley CR. Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis. Br J Dermatol 1989;120:581–4.
  19. Douglas JM. Psoriasis and diet. West J Med 1980;133:450 [letter].
  20. Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438–42.
  21. Galle K, Müller-Jakic B, Proebstle A, et al. Analytical and pharmacological studies on Mahonia aquifolium. Phytomed 1994;1:59–62.
  22. Garg ML, Wierzbicki AA, Thomson ABR et al: Fish oil reduces cholesterol and arachidonic acid more efficiently in rats fed diets containing low linolenic acid to saturated fatty acid ratios. Biochim Biophys Acta 1988; 962:337-344.
  23. Geusens P, Wouters C, Nijs J et al: Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 1994; 37(6):824-829.
  24. Goodnight SH Jr.: The vascular effects of omega-3 fatty acids. J Invest Dermatol 1989; 93:102-106.
  25. Harris, William S. (1985) "Health Effects of Omega-3 Fatty Acids." Contemporary Nutrition, 10:8, August.
  26. Henderson CA, Papworth-Smith J, Cunliffe WJ, et al. A double-blind, placebo-controlled trial of topical 1,25-dihydroxycholecalciferol in psoriasis. Br J Dermatol 1989;121:493–6.
  27. Hoffer, Abram and Walker, Morton (1978) Orthomolecular Nutrition. Keats Publishing, pages 156-157
  28. Hoffman D. The Herbal Handbook: A User’s Guide to Medical Herbalism. Rochester, VT: Healing Arts Press, 1988, 23–4 [review].
  29. Horrobin DF: Interactions between n-3 and n-6 fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation. Prostaglan Leukotr Ess Fatty Acids 1991; 44:127-131.
  30. James MJ, Cleland LG, Gibson RA et al: Interaction between fish and vegetable oils in relation to rat leukocyte leukotriene production. J Nutr 1991; 121(5):631-637.
  31. Jerner B, Skogh M, Vahlquist A. A controlled trial of acupuncture in psoriasis: no convincing effect. Acta Derm Venereol (Stockh) 1997;77:154–6.
  32. Kabat-Zinn J, Wheeler E, Light T, et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 1998;60:625–32.
  33. Kline MV. Psoriasis and hypnotherapy: a case report. Int J Clin Exp Hypn 1954;2:318–22.
  34. Kojima T, Terano T, Tanabe E, et al. Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis. Dermatologica 1991;182:225–30.
  35. Kojima T, Ternao T, Tanabe E, et al. Effect of highly purified eicosapentaenoic acid on psoriasis. J Am Acad Dermatol 1989;21:150–1.
  36. Kojima, T., et al. Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis. Dermatologica, Vol. 182, No. 4, 1991, pp. 225-30
  37. Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment. J Am Acad Dermatol 1992;27:769–71.
  38. Kragballe K, Beck HI, Sogaard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 1988;119:223–30.
  39. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol. Arch Dermatol 1989;125:1647–52.
  40. Liao, SJ. Acupuncture treatment for psoriasis: a retrospective case report. Acupunct Electrother Res 1992;17:195–208.
  41. Lininger S (ed): The Natural Pharmacy. Prima Health Publishing, Rocklin, CA; 1998.
  42. Lorenz R, Spengler U, Fischer S et al: Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 1983; 67(3):504-511.
  43. Marra G, Anti M, Armelao F et al: Rectal epithelial cell proliferation in subjects supplemented with fish oil: a randomized, double-blind trial. In: Drevon CA, Barksaas I & Krokan (eds.): Omega-3 Fatty Acids: Metabolism and Biologic Effects. Birkhauser Verlag, Basel, Switzerland; 1993.
  44. Mayser P, Mrowietz U, Arenberger P, et al. W-3 Fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539–47.
  45. Mehta VR: Side effects of eicosapentaenoic acid and docosahexaenoic acid (MaxEPA). JAPI 1992; 40(6):486.
  46. Mehta VR: Side effects of eicosapentaenoic acid and docosahexaenoic acid (MaxEPA). JAPI 1992; 40(6):486.
  47. Michäelsson G, Gerdén B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 2000;142:44–51.
  48. Michaelsson G, Gerden B. How common is gluten intolerance among patients with psoriasis? Acta Derm Venereol 1991;71:90.
  49. Monk BE, Neill SM. Alcohol consumption and psoriasis. Dermatologica 1986;173:57–60.
  50. Morimoto S, Yoshikawa K, Kozuka T, et al. An open study of vitamin D3 treatment in psoriasis vulgaris. Br J Dermatol 1986;115:421–9.
  51. Morimoto S, Yoshikawa K. Psoriasis and vitamin D3. Arch Dermatol 1989;125:231–4.
  52. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Br J Dermatol 1998;138:456–60.
  53. Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999;141:424–9.
  54. Murray MT. The Healing Power of Herbs. Prima Publishing. Rocklin, CA. 1995, 185-191.
  55. Nieboer C, de Hoop D, Langendijk PN, et al. Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester. Dermatologica 1990;181:33–7.
  56. Nieboer C, de Hoop D, van Loenen AC, et al. Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis. J Am Acad Dermatol 1989;20:601–8 [review].
  57. Norris PG, Jones CHH & Weston MJ: Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br Med J 1986; 293:104.
  58. Nugteren-Huying WM, van der Schroeff JG, Hermans J, Suurmond D. Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 1990;22:311–2.
  59. Oster KA. A cardiologist considers psoriasis Cutis 1977;20:39–40,45.
  60. Pfeiffer, Carl (1978) Zinc and Other Micro-Nutrients. Keats Publishing.
  61. Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 1990;300:780–3.
  62. Pycnogenol: The supreme antioxidant. The Healthy Cell News; Fall/Winter 1996 (6).
  63. Sanders TAB & Hinds A: The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr 1992; 68:163-173.
  64. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000;136:393–9.
  65. Singer P, Jaeger W, Wirth M et al: Lipid and blood-pressure-lowering effect of mackerel diet in man. Atherosclerosis 1983; 49(1):99-108.
  66. Smith EL, Pincus SH, Donovan L, Holick MF. A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 1988;19:516–28.
  67. Soyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med 1993;328:1812–6.
  68. Soyland, E., et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. New England Journal of Medicine, Vol. 328, June 24, 1993, pp. 1812-16
  69. Syed TA, Ahmed SA, Holt AH, et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo-controlled, double-blind study. Tropical Med Inter Health 1996;1:505–9.
  70. Terano T, Fujishiro S, Ban T et al: Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombic cerebrovascular disease. Lipids 1999; 34(suppl):S345-S346.
  71. Van de Kerkhof PCM, Van Bokhoven M, Zultak M, Czarnetzki BM. A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis. Br J Dermatol 1989;120:661–4.
  72. Vorhees, J.G.; Chakrabarti, S.G.; Botero, F.; Meidler, L. and Harrell, E. R. (1969) "Zinc Therapy and Distribution in Psoriasis," Archives of Dermatology, 100:669-673
  73. Wiesenauer M, Lüdtke R. Mahonia aquifolium in patients with psoriasis vulgaris—an intraindividual study. Phytomed 1996;3:231–5.
  74. Zimmerman M. Grape seed standardized extract. L & H Vitamins Inc. Health Newsline; 10. Long Island City, NY.